Streetbeat News

Stock Prices

VTGN

VistaGen Therapeutics announced results from its exploratory Phase 2A study of PH80 in women diagnosed with menopausal hot flashes, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 3:50 pm

AKAM

BIIB

BXP

CRM

GOOGL

SLG

Boston Properties Inc. (BXP) is a well-diversified office REIT with 54.5 million square feet in 192 properties concentrated among six of the largest U.S. cities. As of March 31, BXP had 91% of its in-service properties leased, with a weighted average lease term of 7.6 years. Its top four tenants, Salesforce, Alphabet, Biogen, and Akamai Technologies, account for about 11% of the total annualized base rent. BXP has $15.7 billion in debt and pays a quarterly dividend of $0.98 per share.

Portfolio Pulse from Ethan Roberts

June 07, 2023 | 3:49 pm

NAMS

NewAmsterdam Pharma Company announced a secondary offering by selling shareholders of 10,579,210 shares at €0.12 per share, causing the stock to trade lower.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 3:41 pm

THO

Thor Industries shares are trading higher after multiple firms raised their price targets following better-than-expected Q3 results and an increase in FY23 EPS guidance.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 3:35 pm

CD

Chindata Group Holding has received a preliminary non-binding going private proposal for $8 per share, causing its shares to trade higher.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 3:33 pm

VRA

Vera Bradley reported better-than-expected Q1 adjusted EPS results and raised its FY24 EPS guidance above estimates, leading to a surge in its share prices.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 3:33 pm

TMUS

A whale investor has taken a bullish stance on T-Mobile US (NASDAQ:TMUS), with 55% of detected trades showing bullish expectations and 44% bearish. Whales have been targeting a price range of $70 to $130 for T-Mobile US over the last 3 months. HSBC and Tigress Financial maintain their Buy ratings with price targets of $165 and $204, respectively.

Portfolio Pulse from Benzinga Insights

June 07, 2023 | 3:32 pm

STAA

STAAR Surgical's stock has been downgraded by William Blair from Outperform to Market Perform, causing the shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 3:31 pm

IONS

Ionis Pharmaceuticals announced a $500 million private placement of convertible notes, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 3:31 pm

SNPS

Synopsys (NASDAQ:SNPS) has outperformed the market over the past 20 years, producing an average annual return of 14.2%. A $100 investment in SNPS 20 years ago would be worth $1,474.31 today.

Portfolio Pulse from Benzinga Insights

June 07, 2023 | 3:30 pm